A detailed history of Met Life Investment Management, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 64,736 shares of MRVI stock, worth $286,133. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,736
Previous 28,260 129.07%
Holding current value
$286,133
Previous $202,000 165.84%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.84 - $9.73 $249,495 - $354,911
36,476 Added 129.07%
64,736 $537,000
Q2 2024

Aug 13, 2024

BUY
$6.87 - $11.34 $161,383 - $266,387
23,491 Added 492.58%
28,260 $202,000
Q1 2024

May 14, 2024

BUY
$5.11 - $8.76 $24,369 - $41,776
4,769 New
4,769 $41,000
Q4 2023

Feb 14, 2024

SELL
$4.7 - $9.87 $329 - $690
-70 Reduced 1.45%
4,755 $31,000
Q3 2023

May 09, 2024

SELL
$9.14 - $12.85 $16,707 - $23,489
-1,828 Reduced 27.48%
4,825 $48,000
Q3 2023

Apr 29, 2024

BUY
$9.14 - $12.85 $27 - $38
3 Added 0.06%
4,825 $48,000
Q3 2023

Nov 14, 2023

BUY
$9.14 - $12.85 $27 - $38
3 Added 0.06%
4,825 $48,000
Q2 2023

Apr 29, 2024

BUY
$12.09 - $15.0 $58,297 - $72,330
4,822 New
4,822 $59,000
Q2 2023

Aug 10, 2023

SELL
$12.09 - $15.0 $22,136 - $27,465
-1,831 Reduced 27.52%
4,822 $59,000
Q1 2023

May 09, 2024

BUY
$12.99 - $16.48 $86,422 - $109,641
6,653 New
6,653 $93.2 Million
Q1 2023

May 15, 2023

BUY
$12.99 - $16.48 $194 - $247
15 Added 0.23%
6,653 $93,000
Q4 2022

May 10, 2024

SELL
$12.5 - $24.78 $2,175 - $4,311
-174 Reduced 2.55%
6,638 $94,000
Q4 2022

Jun 14, 2023

SELL
$12.5 - $24.78 $187 - $371
-15 Reduced 0.23%
6,638 $94,000
Q4 2022

Mar 22, 2023

SELL
$12.5 - $24.78 $2,175 - $4,311
-174 Reduced 2.55%
6,638 $94,000
Q4 2022

Feb 15, 2023

SELL
$12.5 - $24.78 $2,175 - $4,311
-174 Reduced 2.55%
6,638 $94,000
Q3 2022

May 10, 2024

BUY
$20.6 - $30.37 $103 - $151
5 Added 0.07%
6,812 $173,000
Q3 2022

Jun 14, 2023

BUY
$20.6 - $30.37 $3,275 - $4,828
159 Added 2.39%
6,812 $173,000
Q3 2022

Mar 22, 2023

BUY
$20.6 - $30.37 $103 - $151
5 Added 0.07%
6,812 $173,000
Q3 2022

Nov 14, 2022

BUY
$20.6 - $30.37 $103 - $151
5 Added 0.07%
6,812 $174,000
Q2 2022

May 10, 2024

SELL
$26.05 - $37.48 $7,658 - $11,019
-294 Reduced 4.14%
6,807 $193,000
Q2 2022

Jun 20, 2023

BUY
$26.05 - $37.48 $4,011 - $5,771
154 Added 2.31%
6,807 $193,000
Q2 2022

Mar 22, 2023

SELL
$26.05 - $37.48 $7,658 - $11,019
-294 Reduced 4.14%
6,807 $193,000
Q2 2022

Aug 11, 2022

SELL
$26.05 - $37.48 $7,658 - $11,019
-294 Reduced 4.14%
6,807 $193,000
Q1 2022

May 10, 2024

BUY
$24.46 - $40.92 $173,690 - $290,572
7,101 New
7,101 $250,000
Q1 2022

Jun 20, 2023

BUY
$24.46 - $40.92 $10,958 - $18,332
448 Added 6.73%
7,101 $250,000
Q1 2022

Mar 22, 2023

BUY
$24.46 - $40.92 $164,395 - $275,023
6,721 Added 1768.68%
7,101 $250,000
Q1 2022

May 12, 2022

BUY
$24.46 - $40.92 $173,690 - $290,572
7,101 New
7,101 $250,000
Q2 2021

Aug 16, 2021

SELL
$32.46 - $45.0 $12,334 - $17,100
-380 Closed
0 $0
Q1 2021

Mar 22, 2023

SELL
$25.8 - $38.49 $161,456 - $240,870
-6,258 Reduced 94.28%
380 $13,000
Q1 2021

May 14, 2021

BUY
$25.8 - $38.49 $9,804 - $14,626
380 New
380 $14,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $581M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.